Clinical trial
UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
NCT00045747 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00045747 |
|---|---|
| Title | UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer |
| Official title | Phase II Study of UCN-01 in Combination With Fluorouracil in Advanced Pancreatic Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | 7-hydroxystaurosporine, fluorouracil |
| Start date | Jul 1, 2002 |
| Completion | Sep 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: